Twist Bioscience to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will participate in fireside chats at the following upcoming investor conferences:

• Baird 2023 Global Healthcare Conference on Tuesday, September 12 in New York, NY; presentation at 1:25 p.m. Eastern Time.
• Goldman Sachs Global Sustainability Forum on Wednesday, September 27 in New York, NY; Circular Economy: Expanding Solutions Across Sectors panel at 12:15 p.m. Eastern Time.

The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20230905716520/en/

Angela Bitting
SVP, Corporate Affairs
925-202-6211
[email protected]

Source: Twist Bioscience Corporation

You May Also Be Interested In

• Cotchett, Pitre & McCarthy Announces a San Mateo County Jury Awards $33 Million to Young Girls Whose Parents Were Killed by 17-Year-Old Who Was Street Racing; Street Racer’s Parents Also Liable
• Margaux REIT Announces Final Closing of Non-Brokered Private Placement of Units
• Anteris Technologies Announces Results for the Second Quarter of 2026